Scout Bio to Present at the 40th Annual Cowen Health Care Conference

PHILADELPHIA--()--Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, today announced that Mark Heffernan, Scout Bio’s Chief Executive Officer, will present a company overview and update at the 40th Annual Cowen Health Care Conference at 10:00 a.m. ET on Tuesday, March 3, 2020 in Boston, MA.

About Scout Bio
Scout Bio is a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. Scout has an exclusive research and development collaboration with the University of Pennsylvania’s Gene Therapy Program, which has been a global leader in gene therapy research and development for nearly three decades. Scout’s therapeutics are designed to induce long-term expression of therapeutic proteins in pet patients using AAV vector technology. Scout Bio is ​a private company headquartered in Philadelphia, Pennsylvania. For more information, please visit www.scoutbio.co.

Contacts

Investor Contact:
Sarah McCabe
Stern Investor Relations, Inc.
212.362.1200
Sarah.Mccabe@sternir.com

Media Contact:
Tom Donovan
Ten Bridge Communications
857.559.3397
tom@tenbridgecommunications.com

Contacts

Investor Contact:
Sarah McCabe
Stern Investor Relations, Inc.
212.362.1200
Sarah.Mccabe@sternir.com

Media Contact:
Tom Donovan
Ten Bridge Communications
857.559.3397
tom@tenbridgecommunications.com